| 1 |
35512805 | Stereoselective metabolism of bupropion to active metabolites in cellular fractions of human liver and intestine. | 2022 May 5 |
1 |
| 2 |
33161206 | Corrigendum to "In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation" [Biochem. Pharmacol. 123(2017)85-96]. | 2021 Jan |
2 |
| 3 |
33905640 | Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With Depression. | 2021 May-Jun 01 |
5 |
| 4 |
34015277 | The Pharmacokinetics of Gefitinib in a Chinese Cancer Population Group: A Virtual Clinical Trials Population Study. | 2021 Oct |
1 |
| 5 |
30842914 | Evaluation of dextromethorphan with select antidepressant therapy for the treatment of depression in the acute care psychiatric setting. | 2019 Mar |
1 |
| 6 |
28876959 | Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion. | 2018 Sep |
3 |
| 7 |
27836670 | In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation. | 2017 Jan 1 |
9 |
| 8 |
29054049 | Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics. | 2017 Oct |
1 |
| 9 |
29267251 | Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model. | 2017 Dec 21 |
2 |
| 10 |
26967321 | Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans. | 2016 |
1 |
| 11 |
27255113 | Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers. | 2016 Aug |
3 |
| 12 |
27300331 | Assessment of a Potential Pharmacokinetic Interaction between Nebivolol and Bupropion in Healthy Volunteers. | 2016 |
1 |
| 13 |
27518170 | Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers. | 2016 Apr-Jun |
1 |
| 14 |
25565674 | Effect of CYP2B6*6 on Steady-State Serum Concentrations of Bupropion and Hydroxybupropion in Psychiatric Patients: A Study Based on Therapeutic Drug Monitoring Data. | 2015 Oct |
1 |
| 15 |
24396053 | Observations on the urine metabolic profile of codeine in pain patients. | 2014 Mar |
1 |
| 16 |
24237812 | Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: role of pharmacogenomics. | 2013 Nov |
1 |
| 17 |
22171584 | Clinically significant drug interactions with newer antidepressants. | 2012 Jan 1 |
1 |
| 18 |
21946596 | [Interactions between metoprolol and antidepressants]. | 2011 Sep 20 |
1 |
| 19 |
20208386 | System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes. | 2010 |
2 |
| 20 |
20880642 | Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions. | 2010 Dec |
1 |
| 21 |
18420781 | An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction. | 2008 Jul |
5 |
| 22 |
18691982 | Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. | 2008 Jul |
1 |
| 23 |
17009913 | Bupropion: pharmacology and therapeutic applications. | 2006 Sep |
2 |
| 24 |
15876900 | Inhibition of CYP2D6 activity by bupropion. | 2005 Jun |
7 |
| 25 |
16368442 | Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. | 2005 Nov |
1 |
| 26 |
12021638 | Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment With bupropion. | 2002 Jun |
5 |
| 27 |
10997936 | CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. | 2000 Oct |
1 |
| 28 |
8885123 | Bupropion plasma levels and CYP2D6 phenotype. | 1996 Oct |
1 |